A preclinical study published in Biological Psychiatry has found that repeated low doses of psilocybin and MDMA reshape ...

New research reveals that psilocybin and MDMA promote long-term PTSD recovery by physically remodeling myelin insulation in ...

Quitting cannabis may yield greater improvements in PTSD symptoms than continued use in adults with both PTSD and cannabis ...

FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for Patients with Comorbid Alcohol Use Disorder PT150 offers a rare, dual-validated ...

A sympathetic nerve block that has shown promise for treatment of post-traumatic stress disorder (PTSD) performed no better than sham treatment in a randomized controlled trial, new research shows.

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

Researchers say they have found physical evidence of PTSD in World Trade Center first responders.